Mondrian Investment Partners LTD increased its stake in Omega Protein Corporation (NYSE:OME) by 9.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 244,104 shares of the company’s stock after buying an additional 20,218 shares during the period. Mondrian Investment Partners LTD’s holdings in Omega Protein Corporation were worth $4,369,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of OME. Victory Capital Management Inc. raised its position in Omega Protein Corporation by 229.0% in the first quarter. Victory Capital Management Inc. now owns 7,850 shares of the company’s stock valued at $157,000 after buying an additional 5,464 shares in the last quarter. Eqis Capital Management Inc. bought a new position in Omega Protein Corporation during the second quarter valued at about $183,000. UBS Group AG raised its position in Omega Protein Corporation by 191.6% in the first quarter. UBS Group AG now owns 12,575 shares of the company’s stock valued at $252,000 after buying an additional 8,262 shares in the last quarter. American International Group Inc. raised its position in Omega Protein Corporation by 7.1% in the first quarter. American International Group Inc. now owns 13,469 shares of the company’s stock valued at $270,000 after buying an additional 892 shares in the last quarter. Finally, KCG Holdings Inc. raised its position in Omega Protein Corporation by 83.2% in the first quarter. KCG Holdings Inc. now owns 15,339 shares of the company’s stock valued at $308,000 after buying an additional 6,964 shares in the last quarter. Institutional investors and hedge funds own 84.01% of the company’s stock.

Shares of Omega Protein Corporation (NYSE OME) opened at 15.85 on Friday. Omega Protein Corporation has a 52 week low of $15.60 and a 52 week high of $26.99. The company’s 50-day moving average price is $16.63 and its 200 day moving average price is $19.70. The firm has a market cap of $356.05 million, a P/E ratio of 11.09 and a beta of 0.21.

Omega Protein Corporation (NYSE:OME) last issued its quarterly earnings data on Wednesday, August 2nd. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.08. Omega Protein Corporation had a net margin of 8.95% and a return on equity of 10.46%. The company had revenue of $93.90 million for the quarter, compared to analysts’ expectations of $87.44 million. During the same quarter in the previous year, the firm posted $0.62 earnings per share. Omega Protein Corporation’s revenue for the quarter was down 16.7% on a year-over-year basis. On average, equities analysts anticipate that Omega Protein Corporation will post $1.07 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Friday, August 25th will be paid a $0.05 dividend. The ex-dividend date is Wednesday, August 23rd. This represents a $0.20 annualized dividend and a dividend yield of 1.26%. Omega Protein Corporation’s dividend payout ratio is 14.08%.

WARNING: “Mondrian Investment Partners LTD Buys 20,218 Shares of Omega Protein Corporation (NYSE:OME)” was posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/mondrian-investment-partners-ltd-buys-20218-shares-of-omega-protein-corporation-nyseome.html.

OME has been the topic of several recent research reports. Pivotal Research reduced their price target on Omega Protein Corporation from $18.00 to $15.00 and set a “hold” rating on the stock in a research report on Friday, July 7th. ValuEngine lowered Omega Protein Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Zacks Investment Research upgraded Omega Protein Corporation from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 10th. Finally, BidaskClub lowered Omega Protein Corporation from a “sell” rating to a “strong sell” rating in a research report on Wednesday, July 19th. One investment analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. Omega Protein Corporation presently has a consensus rating of “Hold” and a consensus price target of $21.50.

Omega Protein Corporation Company Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Want to see what other hedge funds are holding OME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Protein Corporation (NYSE:OME).

Institutional Ownership by Quarter for Omega Protein Corporation (NYSE:OME)

Receive News & Ratings for Omega Protein Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein Corporation and related companies with MarketBeat.com's FREE daily email newsletter.